Document is current
Any future updates will be listed below
-
Authors
Zou, Tianxiao
Yang, Xueting
Ren, Lulu
Wei, Sisi
Wang, Guoqing
Wei, Rong
Yu, Shenghua
-
Funding
Funding for this research was provided by:
Clinical Research Training Program of Shanghai Children's Hospital (2023YLY08)
Clinical Research Training Program of Shanghai Children's Hospital (2023YLY08)
Clinical Research Training Program of Shanghai Children's Hospital (2023YLY08)
Clinical Research Training Program of Shanghai Children's Hospital (2023YLY08)
Clinical Research Training Program of Shanghai Children's Hospital (2023YLY08)
Clinical Research Training Program of Shanghai Children's Hospital (2023YLY08)
Clinical Research Training Program of Shanghai Children's Hospital (2023YLY08)
- License Information
-
More Information
Article History
Received: 21 May 2025
Accepted: 20 August 2025
First Online: 2 October 2025
Declarations
:
: The studies involving human participants were reviewed and approved by Institutional Review Board of Shanghai Children’s Hospital, Shanghai Written informed consent was taken from all the patients. This study was registered in Chinese Clinical Trial Registry (No. ChiCTR2300076270, 28-09-2023) where the trial protocol could be accessed. All adverse events were immediately reported to the Ethics Committee (within 24 h for serious events). Events were categorized by severity with appropriate actions taken. Affected participants were monitored until complete resolution. All cases were reviewed by the research team.
: Not applicable.
: The authors declare no competing interests.
